When should we use tirofiban in acute MI?
In this video, Dr. Viveka Kumar, Senior Director - Cath Lab, Max Super Speciality Hospital, Saket will talk on tirofiban usage in acute MI. Tirofiban is an anti-platelet which is injectable and is given in situations where the risk of clot formation is high such as huge thrombus burden in large arteries or in primary PCI situation. He will also explain that it is given in patients who has a high platelet count. He will also discuss the situations where the tirofiban is not indicated.
Dr. Viveka Kumar
Dr. Viveka Kumar is a Senior Consultant Interventional Cardiologist and Director of the Cath Lab at Max Super Speciality Hospital in Saket, New Delhi. He completed his MBBS and MD (Medicine) from IMS (BHU), Varanasi and later obtained the DM (Cardiology) postdoc, superspeciality degree through GSVM Medical College, Kanpur. Has extensive experience in the field of Cardiac interventions and Electrophysiology. Specializes in complex angioplasties including multivessel, bifurication and left main angioplasties with Rota Ablation, FFR, IVUS, IABP, IMPELLA devices. Has done more than 7500 angioplasties and 2500 balloon valvotomies with good outcomes.
More FAQs by Dr. Viveka Kumar
Medtalks is India's fastest growing Healthcare Learning and Patient Education Platform designed and developed to help doctors and other medical professionals to cater educational and training needs and to discover, discuss and learn the latest and best practices across 100+ medical specialties. Also find India Healthcare Latest Health News & Updates on the India Healthcare at Medtalks
Please login to comment on this article